The following individual and combined search terms were used: GLP-1, Semaglutide and Liraglutide, molecular mechanism, lipid metabolism, insulin metabolism, glucose homeostasis, energy expenditure obesity treatment, type 2 diabetes mellitus, side effects, clinical trials, treatment option, fatty liver disease, hypertension, neurodegenerative diseases, cardiovascular diseases, therapeutic options. Only articles published in the last 10 years are included, although older pivotal studies were added
Link Ro
Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date
Phase 3: months 3 through 6 (optimization) You are now an experienced semaglutide user
Some patients report headaches , particularly in the early treatment phase
GLP-1 enhances insulin secretion